Institutional investors purchased a net $26.6 million shares of OPK during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 22.53% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AMITIM SENIOR PENSION FUNDS Bought 616.2 Thousand shares of OPKO Health Inc
OXFORD ASSET MANAGEMENT LLP Bought 356.3 Thousand shares of OPKO Health Inc
TEWKSBURY CAPITAL MANAGEMENT LTD... Bought 121.6 Thousand shares of OPKO Health Inc